21201 ⎘
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant; Organic adjuvants Polysaccharides
POLYMERIC NANOVACCINES AND USES THEREOF
#2NOVEL ADJUVANT FOR ANIMAL AND HUMAN VACCINES
#3VACCINE COMPRISING PERIPHERAL BLOOD MONONUCLEAR CELLS LOADED WITH NATURAL KILLER T CELL LIGAND AND ANTIGEN
#4PNEUMOCOCCAL CONJUGATE VACCINES WITH SAPONIN-BASED ADJUVANTS
#5VACCINE ADJUVANTS AND FORMULATIONS
#6INTRANASAL POLYSACCHARIDE CONJUGATE NANOMULSION VACCINES AND METHODS OF USING THE SAME
#7ADJUVANT COMPOSITION CONTAINING GALACTAN STRUCTURE AND USES THEREOF
#8ADJUVANT FOR BACILLUS CALMETTE-GUERIN CANCER IMMUNOTHERAPY
#9VACCINATION IN NEWBORNS AND INFANTS
#10VACCINATION IN NEWBORNS AND INFANTS
#11VACCINE COMPOSITION
#12BLETILLA STRIATA POLYSACCHARIDE, PREPARATION METHOD AND USE THEREOF, IMMUNE ADJUVANT AND NANO VACCINE CONTAINING THE SAME
#13UNIVERSAL ADJUVANT FOR NASAL, ORAL, AND INTRAMUSCULAR DELIVERY OF VACCINES
#14M-cell GP2-mediated lymphatic-targeted drug carriers
#15POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS
#16MULTIVALENT VACCINE COMPOSITIONS AND USES THEREOF
#17Neisseria Meningitidis Vaccine
#18GLYCATED CHITOSANS FOR TREATMENT OF VIRAL INFECTIONS
#19ZWITTERIONIC HYDROGEL DEPOT FOR EXTENDED ANTIGEN AND VACCINE DELIVERY
#20OIL-BASED ADJUVANTS
#21INJECTABLE HYDROGEL FOR SUSTAINED CO-DELIVERY OF AN ANTIGEN AND AN ADJUVANT, AND USES THEREOF
#22COMPOSITION FOR ENHANCING IMMUNOGENICITY
#23ADJUVANT COMPOUNDS AND FORMULATIONS
#24BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT
#25MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER
#26MOLECULAR VACCINES FOR INFECTIOUS DISEASE
#27TRITERPENE SAPONIN ANALOGUES
#28Method of Conferring a Protective Immune Response to Norovirus
#29POLYSACCHARIDE COMPLEX
#30METHODS OF TREATING AUTOIMMUNE DISEASE
#31TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES
#32ADJUVANT AND VACCINE CONTAINING ADJUVANT
#33A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA
#34Foot-and-mouth disease vaccine
#35NANOGEL-COATED VACCINE
#36CATH2 AND DERIVATIVES FOR INHIBITING STREPTOCOCCUS SUIS
#37POLYSACCHARIDE ADJUVANTS FOR VIRUS VACCINES
#38CANCER VACCINE AND METHOD OF USE THEREOF
#39UNIVERSAL ADJUVANT FOR NASAL, ORAL, AND INTRAMUSCULAR DELIVERY OF VACCINES
#40CHITOSAN-DERIVED COMPOSITIONS
#41YEAST GLUCANS, METHODS AND USES THEREOF
#42ADJUVANT FOR ANIMAL AND HUMAN VACCINES
#43EXPEC GLYCOCONJUGATE VACCINE FORMULATIONS
#44Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells
#45VACCINE ADJUVANTS AND FORMULATIONS
#46Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses
#47IMMUNOMODULATORY AGENT
#48Oil-based adjuvants
#49USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION
#50PARTICLE BASED FORMULATION OF SARS-COV-2 RECEPTOR BINDING DOMAIN
#51Polysaccharide and uses thereof
#52Vaccine Compositions and Antibodies For Lyme Disease
#53DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING BETA-GLUCAN AS A VACCINE ADJUVANT
#54NOROVIRUS VACCINE
#55NEISSERIA MENINGITIDIS VACCINE
#56AMHR2-ED CANCER VACCINE FORMULATIONS
#57VACCINATION IN NEWBORNS AND INFANTS
#58Triterpene saponin analogues
#59PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE mRNA CONSTRUCT
#60BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT
#61IMMUNOGENIC COMPLEX FOR ELICITING PROTECTIVE IMMUNITY AGAINST GROUP B STREPTOCOCCUS
#62ANTI-MULLERIAN HORMONE RECEPTOR 2 ANTIBODIES AND METHODS OF USE
#63METHOD FOR MONITORING STABILITY OF POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
#64Methods and compositions for immune protection against extra-intestinal pathogenic
#65PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY
#66HPV VACCINE
#67NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF
#68COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES
#69Production of 018 bioconjugates
#70BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE
#71Compositions and methods of enhancing immune responses to or limiting infection
#72METHODS FOR TREATING SOLID TUMORS
#73Vaccine Adjuvants for Antigen Delivery
#74Method and system for protecting monarch butterflies from pesticides
#75NEUTRALIZING VACCINES AGAINST HUMAN CORONAVIRUS
#76Method of conferring a protective immune response to Norovirus
#77NEOANTIGENS IN CANCER
#78BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT
#79POLYMERIC NANOVACCINES AND USES THEREOF
#80METHODS FOR IDENTIFYING BETA-GLUCAN BINDING TO IMMUNE CELLS
#81Foot-and-mouth disease vaccine
#82Multivalent vaccine compositions and uses thereof
#83COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE
#84LOW CONTAMINANT COMPOSITIONS
#85IMMUNOMODULATORY PHARMACEUTICAL COMPOSITIONS INCLUDING A SYNTHETIC PEPTIDE AND TRANSFORMING GROWTH FACTOR BETA
#86Chitosan-derived compositions
#87IMMUNOGENIC COMPOSITIONS
#88Neisseria meningitidis vaccine
#89HYALURONIC ACID AS A NATURAL ADJUVANT FOR PROTEIN AND PEPTIDE-BASED VACCINES
#90COMBINATION THERAPY WITH NEOANTIGEN VACCINE
#91Vaccine adjuvants and formulations
#92Oral dispersible vaccine comprising virosomes
#93Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
#94FLAGELLIN COMPOSITIONS AND USES
#95INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
#96Low contaminant compositions
#97ExPEC glycoconjugate vaccine formulations
#98Flagellin-based agents and uses including effective vaccination
#99COMPOSITION AND METHOD FOR STABILISING VACCINES IN A SOLID DOSAGE FORMAT
#100METHODS OF ENHANCING IMMUNOGENICITY OF POORLY IMMUNOGENIC ANTIGEN-SPECIFIC VACCINES USING ORAL YEAST BETA-GLUCANS
#101Multi-epitopic peptide compounds and vaccines against leishmaniasis
#102Vaccine compositions
#103Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof
#104Method and system for protecting honey bees from pesticides
#105Oil-based adjuvants
#106Polysaccharide and uses thereof
#107Immunogenic complex for eliciting protective immunity against group B
#108Methods and compositions for immune protection against extra-intestinal pathogenic
#109Vaccine compositions comprising a water-in-oil emulsion, immunogen-loaded hydrogel particles, and cationic polymer
#110Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells
#111VACCINATION IN NEWBORNS AND INFANTS
#112Compositions and methods for vaccination against respiratory syncytial virus infection
#113Coccidioides antigens and methods of their use
#114Immunopotentiator, foot-and-mouth disease inactivated vaccine and preparation method thereof
#115Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
#116Mucosal adjuvants and delivery systems
#117Flagellin-based agents and uses including effective vaccination
#118Adjuvant for animal and human vaccines
#119Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta
#120Compositions and methods for a multi-adjuvant only approach to immunoprophylaxis for preventing infections
#121System and method for allergen-specific epicutaneous immunotherapy
#122Norovirus vaccine
#123Method of conferring a protective immune response to norovirus
#124Chitosan-derived compositions
#125Fucoidan-quaternized chitosan nanoparticles and application thereof
#126Coccidiosis vaccine
#127Vaccination in newborns and infants
#128Method and system for protecting honey bees from pesticides
#129FILOVIRUS VACCINES AND METHODS OF USE
#130Flagellin compositions and uses
#131COMPOSITION AND MANUFACTURING OF POWDERS CONTAINING NANOADJUVANTS FOR MUCOSAL VACCINATION
#132Use of phosphorylated heptose compounds
#133Methods and compositions employing immunogenic fusion proteins
#134Triterpene saponin analogues
#135Means and methods for producing phosphate containing capsular polysaccharides
#136METHOD OF INDIRECT IMMUNIZATION OF HUMAN OVARIAN CANCER PATIENTS THROUGH SELECTION OF XENOGENEIC IMMUNOGLOBULIN FC PORTIONS
#137Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#138Oral dispersible vaccine comprising virosomes
#139Polysaccharide and uses thereof
#140Modified lipopolysaccharide glycoform and method of use
#141Tumor vaccine and uses thereof
#142ExPEC glycoconjugate vaccine formulations
#143Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant
#144METHOD OF INDIRECT IMMUNIZATION OF HUMAN OVARIAN CANCER PATIENTS THROUGH SELECTION OF XENOGENEIC IMMUNOGLOBULIN FC PORTIONS
#145Foot-and-mouth disease vaccine
#146Methods and compositions to increase immune response to vaccines
#147PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS
#148ORAL PHARMACEUTICAL COMPOSITION
#149Method of conferring a protective immune response to norovirus
#150Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A
#151Flagellin-based agents and uses including effective vaccination
#152Immunomodulatory pharmaceutical compositions
#153Molecular vaccines for infectious disease
#154Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
#155Compositions and methods of enhancing immune responses to or limiting infection
#156Immunogenic complex for eliciting protective immunity against group b streptococcus
#157Interferon Therapy
#158Flagellin compositions and uses
#159Mucosal adjuvants and delivery systems
#160Adjuvant System for Vaccine Administration
#161Human rhinovirus vaccine
#162Microparticulated Vaccines for the Oral or Nasal Vaccination and Boostering of Animals Including Fish
#163Recombinant influenza virus-like particles (VLPS) produced in transgenic plants
#164vaccine
#165Vaccination in newborns and infants
#166Adjuvanting meningococcal factor H binding protein
#167Method and system for protecting honey bees from fipronil pesticides
#168Scaffolds for cell transplantation
#169Complex containing oligonucleotide having immunopotentiating activity and use thereof
#170ExPEC glycoconjugate vaccine formulations
#171ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#172Bacteriophage-polymer hybrid
#173Vaccination in newborns and infants
#174Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, and their use
#175Oil-based adjuvants
#176Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#177Long chain antigen containing interepitope sequence that promotes antigen presentation to T cells
#178Chitosan-Derived Compositions
#179COMPOSITIONS AND METHODS FOR BETA-GLUCAN IMMUNOTHERAPY
#180FLAGELLIN-BASED AGENTS AND USES INCLUDING EFFECTIVE VACCINATION
#181PORCINE EPIDEMIC DIARRHEA VIRUS VACCINES AND METHODS OF USE THEREOF
#182Vaccine compositions
#183Chitosan-derived compositions
#184Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
#185Polymer conjugate vaccines
#186Foot-and-mouth disease vaccine
#187IMMUNOGENIC GLYCOPEPTIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#188LONG CHAIN INULIN FOR STIMULATING AN IMMUNE RESPONSE
#189Flagellin compositions and uses
#190Methods and compositions for immune protection against extra-intestinal pathogenic
#191Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#192ILEUM-TARGETING, MUCOADHESIVE THIOLATED HPMCP VACCINE PROTEIN DELIVERY AGENT
#193Adjuvant for vaccines, vaccine, and immunity induction method
#194Vaccine adjuvant composition comprising inulin particles
#195Compositions and methods of enhancing immune responses to or limiting infection
#196ADJUVANT PARTICLES COMPRISING ADENOSINE RECEPTOR ANTAGONISTS
#197Prime-boost regimens involving administration of at least one mRNA construct
#198ExPEC glycoconjugate vaccine formulations
#199Compositions and methods for producing bacterial conjugate vaccines
#200Optimized cancer stem cell vaccines
#201Methods and compositions employing immunogenic fusion proteins
#202Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#203Macrophages eat cancer cells using their own calreticulin as a guide
#204COMPOSITIONS AND METHODS RELATED TO NEUROLOGICAL DISORDERS
#205Adjuvanting meningococcal factor H binding protein
#206Polysaccharide and uses thereof
#207Detoxification method for lipopolysaccharide (LPS) or lipid A of Gram-negative bacteria
#208METHOD FOR THE CANCER TREATMENT AND PREVENTION OF METASTATIC DISEASE
#209Compositions including beta-glucans and method of use
#210Flagellin-based agents and uses including effective vaccination
#211Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same
#212VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION
#213Pharmaceutical cyclosporin compositions
#214Modified lipopolysaccharide glycoform and method of use
#215COMPOSITIONS AND METHODS RELATED TO NEUROLOGICAL DISORDERS
#216Therapy-enhancing glucan
#217IMMUNE MODULATION FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#218Interferon therapy
#219CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY
#220Methods for effectively and rapidly desensitizing allergic patients
#221Vaccination in newborns and infants
#222Oral pharmaceutical composition
#223Vaccination response for immunodeficiency disorders or high cortisol
#224Mucosal adjuvants and delivery systems
#225Antigen-loaded chitosan nanoparticles for immunotherapy
#226Non-digestible sugar-coated products and process
#227Tannin-chitosan composites
#228Immunostimulatory nanocomplex
#229Double-stranded RNA conjugates and their use
#230Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin
#231Porcine epidemic diarrhea virus vaccines and methods of use thereof
#232Combinatorial platform for the display of surface adjuvants and antigens
#233A Composition Comprising Ex-Vivo Generated Dendritic Cells
#234BIOMARKERS FOR PROSTATE CANCER AND METHODS FOR THEIR DETECTION
#235Biodegradable nanocomplex
#236Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#237Immunogens and methods for discovery and screening thereof
#238Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
#239Vaccine compositions
#240Multivalent stable vaccine composition and methods of making same
#241T CELL INDUCING VACCINE CONTAINING AN INTEREPITOPE SEQUENCE THAT PROMOTES ANTIGEN PRESENTATION
#242IMMUNOMODULATING COMPOSITIONS AND METHODS OF USE THEREOF
#243Traditional chinese medicine mulberry leaves polysaccharide and eucommia polysaccharide immunostimulant and application thereof
#244Extract of algae for use as an immunomodulator agent
#245Scaffolds for cell transplantation
#246Scaffolds for cell transplantation
#247Immunopotentiator
#248Arabinogalactan for enhancing the adaptive immune response
#249Complex containing oligonucleotide having immunopotentiating activity and use thereof
#250Vaccine
#251Pharmaceutical cyclosporin compositions
#252Compositions and methods for diagnosing, preventing and treating and infection
#253Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
#254Sphingoglycolipid analogues
#255Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions
#256Vaccine formulation for ocular immunization
#257Refined product obtained from rice hull and preparation process and use thereof
#258Immunogenic complex for vaccination and method for the production thereof
#259Immunogenic composition
#260Immunogenic composition in emulsion form
#261Bovine virus vaccines that are liquid stable
#262Methods and compositions employing immunogenic fusion proteins
#263Polysaccharide fraction originating in persimmon leaf with immunostimulating activation and antitumor activation and method for manufacturing same
#264Vaccine combinations
#265Compositions and methods of enhancing immune responses to or limiting infection
#266Oral pharmaceutical composition
#267Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists
#268Immunologically active compositions
#269Modified lipopolysaccharide glycoform and method of use
#270Bifidobacterium for dust mite allergy
#271Immunomodulating compositions and uses therefor
#272Polysaccharide and uses thereof
#273BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE
#274Veterinary vaccine
#275Detoxified endotoxin immunogenic compositions and uses thereof
#276Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
#277Oil-based adjuvants
#278Methods for identifying beta-glucan binding to immune cells
#279Compositions and methods for beta-glucan immunotherapy
#280NATURAL SAPONIN-BASED SYNTHETIC IMMUNOADJUVANTS
#281Method of enhancing the proliferative phase of a primary T cell response
#282Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
#283CHITOSAN-DERIVED COMPOSITIONS
#284Nutritional composition for improving the mammalian immune system
#285Therapy-enhancing glucan
#286Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
#287Compositions including β-glucans and methods of use
#288Vaccine adjuvant composition comprising inulin particles
#289Immunomodulating compositions and methods of use thereof
#290Arabinogalactan for enhancing the adaptive immune response
#291Bovine virus vaccines that are liquid stable
#292Inactivated chikungunya viruses (CHIKV) comprising an E1-K211E mutation
#293Zwitterionic immunomodulators for the treatment of asthma and allergy
#294Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
#295Methods and compositions employing immunogenic fusion proteins
#296Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
#297Pharmaceutical cyclosporin compositions
#298Adjuvant system for vaccine adjuvant
#299Use of high molecular weight mannan for inducing and/or enhancing an immune response
#300Influenza virus-like particles (VLPS) comprising hemagglutinin produced within a plant